Skip to main content
Premium Trial:

Request an Annual Quote

A Matter of Access?

Over at his blog this week, the Washington Post’s Ezra Klein discusses the impact of genomic medicine on what he calls "the coming explosion in healthcare inequality." According to Klein, should genome-based medicine come to fruition, such that "we’ll be able to use the information contained in an individual's DNA sequence to target their therapies much more precisely," healthcare inequality will increase. Klein says that as personalized treatments come online, "we should expect that someone who can pay for the best treatments for their particular DNA sequences to achieve far better health-care outcomes than someone who can't afford the best treatments and has to settle for general therapies rather than individualized medicine." However, he adds that in the future, "to be sure ... both the poor and the rich" will receive better treatment than either group can access now.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.